TGA Australia
198
Seguidores
Personal Information
Organização/Local de trabalho
Symonston, ACT Australia
Setor
Government / Military
Site
www.tga.gov.au
Marcadores
therapeutic goods administration
tga
presentation
medical devices
regulatory reforms
regulation
regulations
complementary medicines
arcs
medicine
presentations
therapeutic goods
medical device
advertising
pharmacovigilance
medicines
australia
good manufacturing practice
training
prescription medicine
post-market
medicines regulation
sponsor information
risk
medicinal cannabis
prescription medicines
compliance
arcs 2016
biologicals
clinical trials
management
inspection program
plan
therapeutic goods legislation
medical devices workshop
risk management plans
ivds
gmp
clinical evidence
ectd
generic medicines
scheduling policy framework
pic/s
regulation of medical devices
regulatory
regulatory guidance
regulatory frameworks
manufacturing
clinical trial notification
overview
ebs
conformity assessment
information
guide
tga guidance
permitted indications
quality standards
mmdr
labelling/packaging
therapeutic goods order
evaluation
software
tbs
adverse events
application process
business
requirements
legislation
safety
regulatory requirements
advertising complaints handling
electronic submissions
advertising reforms
webinar
tga compliance
patient education
risk management
medicine labels
reform
activities
data integrity
tissues
cma
ivd
pre-market
manufacturing quality
inspection process
stem cells
questions
ebusiness
medicine shortages
recall
changes
international
therapeutic
faecal microbiota transplantation
consultation
digital
listed medicines
enterprise
advertising code
fees and charges
sme assist
guidelines
non-prescription medicines
gmp clearance
regulatory environment
medicine labelling
adverse reporting
office of drug control
scheduling
risk minimisation
clinical evaluation reports
autologous
cells
cell therapy
evaluating risk
gmp requirements
international harmonisation
human cellular therapy
therapeutic goods regulation
minimisation
monitoring
audit assessments
pharmacopoeias
tgo
tga business services
ctn
pilot programme
administrator
periodic safety update reports
australian specific annex
prescriptions
esubmissions
consumers
application audits
non recall
artg
sponsor
process
communication
industry
rmp
submission
electronic
otc
review
products
tissue
complementary medicine safety
digital medical devices
adverse event management system
international collaboration
pvip
evidence based
cmi template
consumer medicine information
otc medicines
methodologies
regulatory guidelines
regulatory pathways
gene therapies
biologcal therapies
good clinical practice
human cells and tissues
medicnes
2d datamatrix codes
human cells and tissue regulation
generic medicines reform program
section 19a
compliance framework
post market monitoring
unique device identification
3d printed devices
personalised medical devices
software as a medical device
health
acss consortium
global compliance
market authorisation evidence
comparable overseas regulators
information leaflets
patient implant cards
registered medicines
custom made medical devices
quality risk management systems
cybersecurity
international work-sharing pilot
manufacturing principles
device vigilance
assessed listed medicines
supply chain
complaints system
poisons standard
schedule 3 substances
market analysis
international society of pharmacovigilance
provisional approval pathways
pathways
pe009-13
therapeutic innovation australia symposium
toxicology
chemistry
conference
consortium
parenteral drug association (australia)
pda
medsearch app
orphan drugs
bioavailability
bioequivalence
supply and distribution
vigilance requirements
performance requirements
manufactured overseas
sanctions
penalties
global
electronic form
e-form
minor variation
access schemes
tgo93
regulatory issues
tgo 92
tgo 91
single use devices
asmi annual conference
hprg
sunscreens
nanotechnology
nanoparticle
nanotherapeutics
nanomedicines
certification
licensing
biovigilance
sponsor roles
sponsor responsibilities
epidemiological
influenza immunisation
research
engineers
scientists
public service
pre-clinical studies
on-going monitoring
incident reporting
annual reporting
post-market reviews
qms
quality management system
cannabis
cbd
cannabinoids
thc
odc
asa
european medicines agency
ema
european public assessment report
auspars
australian public assessment reports
epars
international regulation
high risk devices
urptg
recalls
iprf
icmra
icdra
international generic drug regulators programme
ich
igdrp
imdrf
mdsap
regulatory obligations
custom-made
legislative framework
ingredient names
medical devices/ivds
australian orthopaedics association
implant registry data
experience with aoanjrr
national joint replacement registry
risk minimisation effectiveness
online
therapies
breakthrough
cleaning validation
contamination control
infectious disease
business improvement program
effectiveness
measuring
application
identification
manufacturer's evidence
tga expectations
blood
regulation of in vitro diagnostic medical devices
goods packaging
quality
illegal
annual charge exemption
annual charges
low value turnover
ace
ctx
unapproved therapeutic goods
ebusiness services
australian reflection
regulatory convergence
module 3
biologics
protein
peptide
biosimiars
extrapolation
indications
food-like
legal
improvements
business services
impurities
forum
lbs
literature based submissions
risk minimisation activities
submitter
drafter
pilot
psur
travelling
unapproved
post-market responsibilities (ii)
post-market responsibilities (i)
decision making and reviews
accurate manufacturers evidence
post-market vigilance activities
initiative
msi
shortages
registration
clearance
acpm
committee
advisory
psc
biosimilars
prescription
dossier
convergence
cooperation
packaging
labelling
microbiology
injectables
cosmetic
benefits
postmarket
monitor
listed
registered
manufacture
education
student
device
cell
biological
Ver mais
- Apresentações
- Documentos
- Infográficos